DOI: 10.1055/s-00000004

Aktuelle Neurologie

References

Ziemssen T, Neuhaus O, Hohlfeld R.
Risk-benefit assessment of glatiramer acetate in multiple sclerosis.

Drug Safety 2001;
24: 979-990

Download Bibliographical Data

Search in:
Access: